Yu Ke1, Hanzhang Zhou1, Raymond Javan Chan2,3,4, Alexandre Chan5. 1. Department of Pharmacy, National University of Singapore, Singapore, Singapore. 2. Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Bedford Park, SA5042, Australia. 3. School of Nursing, Queensland University of Technology, Kelvin Grove, Australia. 4. Princess Alexandra Hospital, Metro South Hospital and Health Services, Woolloongabba, QLD, Australia. 5. Department of Clinical Pharmacy Practice, University of California Irvine, Irvine, CA, USA. a.chan@uci.edu.
Abstract
PURPOSE: To elucidate existing decision aids (DAs) in supporting cancer survivors' decisions to engage in cancer survivorship care services after primary treatment. Secondary objectives are to assess the DA acceptability, impact of DAs, and implementation barriers. METHODS: Databases (PubMed, Embase, PsycINFO, CINAHL) were searched to collect publications from inception through September 2021. Studies describing the development or evaluation of DAs used for survivorship care services after primary cancer treatment were included. Article selection and critical appraisal were conducted independently by two authors. RESULTS: We included 16 studies that described 13 DAs and addressed multiple survivorship care domains: prevention of recurrence/new cancers in Hodgkin lymphoma survivors and breast cancer gene mutation carriers, family building options, health insurance plans, health promotion (substance use behavior, cardiovascular disease risk reduction), advanced care planning, and post-treatment follow-up intensity. The electronic format was used to design most DAs for self-administration. The content presentation covered decisional context, options, and value clarification exercises. DAs were acceptable and associated with higher knowledge but presented inconclusive decisional outcomes. Implementation barriers included lack of design features for connectivity to care, low self-efficacy, and low perceived DA usefulness among healthcare professionals. Other survivor characteristics included age, literacy, preferred timing, and setting. CONCLUSIONS: A diverse range of DAs exists in survivorship care services engagement with favorable knowledge outcomes. Future work should clarify the impact of DAs on decisional outcomes. IMPLICATIONS FOR CANCER SURVIVORS: DA characterization and suggestions for prospective developers could enhance support for cancer survivors encountering complex decisions throughout the survivorship continuum.
PURPOSE: To elucidate existing decision aids (DAs) in supporting cancer survivors' decisions to engage in cancer survivorship care services after primary treatment. Secondary objectives are to assess the DA acceptability, impact of DAs, and implementation barriers. METHODS: Databases (PubMed, Embase, PsycINFO, CINAHL) were searched to collect publications from inception through September 2021. Studies describing the development or evaluation of DAs used for survivorship care services after primary cancer treatment were included. Article selection and critical appraisal were conducted independently by two authors. RESULTS: We included 16 studies that described 13 DAs and addressed multiple survivorship care domains: prevention of recurrence/new cancers in Hodgkin lymphoma survivors and breast cancer gene mutation carriers, family building options, health insurance plans, health promotion (substance use behavior, cardiovascular disease risk reduction), advanced care planning, and post-treatment follow-up intensity. The electronic format was used to design most DAs for self-administration. The content presentation covered decisional context, options, and value clarification exercises. DAs were acceptable and associated with higher knowledge but presented inconclusive decisional outcomes. Implementation barriers included lack of design features for connectivity to care, low self-efficacy, and low perceived DA usefulness among healthcare professionals. Other survivor characteristics included age, literacy, preferred timing, and setting. CONCLUSIONS: A diverse range of DAs exists in survivorship care services engagement with favorable knowledge outcomes. Future work should clarify the impact of DAs on decisional outcomes. IMPLICATIONS FOR CANCER SURVIVORS: DA characterization and suggestions for prospective developers could enhance support for cancer survivors encountering complex decisions throughout the survivorship continuum.
Authors: Jet W Ankersmid; Constance H C Drossaert; Yvonne E A van Riet; Luc J A Strobbe; Sabine Siesling Journal: J Cancer Surviv Date: 2022-02-04 Impact factor: 4.442
Authors: Doris Howell; Deborah K Mayer; Richard Fielding; Manuela Eicher; Irma M Verdonck-de Leeuw; Christoffer Johansen; Enrique Soto-Perez-de-Celis; Claire Foster; Raymond Chan; Catherine M Alfano; Shawna V Hudson; Michael Jefford; Wendy W T Lam; Victoria Loerzel; Gabriella Pravettoni; Elke Rammant; Lidia Schapira; Kevin D Stein; Bogda Koczwara Journal: J Natl Cancer Inst Date: 2021-05-04 Impact factor: 13.506